Xinli Gan | Health, Safety, and Environment (HSE) | Innovative Research Award

 

Innovative Research Award

Xinli Gan
Guizhou Institute of Technology, China

Xinli Gan
Affiliation Guizhou Institute of Technology
Country China
Scopus ID 56102404000
Documents 23
Citations 157
h-index 7
Subject Area Health, Safety, and Environment (HSE)
Event Petroleum Engineering Awards
ORCID 0000-0002-7958-9078

Xinli Gan is a researcher affiliated with Guizhou Institute of Technology, China, whose supplied publication record includes studies on asphalt pavement materials, phase-change microcapsules, and carbon nanotube applications in construction materials. These topics connect material performance with pavement functionality, waste recovery, and potential engineering sustainability. The Innovative Research Award profile presented here summarizes the available bibliographic information and considers its relevance to research innovation and the broader Health, Safety, and Environment (HSE) field. The supplied Scopus profile reports 23 documents, 157 citations, and an h-index of 7; these figures should be interpreted in the context of the profile’s current indexing and update date. [1]

 Abstract

This article presents a research profile of Xinli Gan based on the bibliographic details supplied for the Innovative Research Award. The available publication information highlights investigations into asphalt pavement sealant materials incorporating phase-change microcapsules and the growth of carbon nanotubes on fly ash as a waste-recovery strategy. These topics reflect research at the intersection of construction materials, functional performance, and resource utilization. The reported Scopus metrics provide a quantitative snapshot of scholarly output and citation activity, but do not independently establish the quality or practical impact of individual studies. Full-text access, detailed methods, DOI identifiers, and complete author-contribution information were not supplied and require verification before publication. [1]

 Keywords

Xinli Gan; innovative research; asphalt pavement; phase-change microcapsules; anti-skid sealants; carbon nanotubes; fly ash recovery; construction materials; material performance; environmental sustainability; Health, Safety, and Environment; petroleum engineering recognition.

 Introduction

Research into advanced construction materials can contribute to improved infrastructure performance and more efficient use of resources. Asphalt pavement studies, in particular, address surface functionality, durability, and safety under changing environmental conditions. Incorporating phase-change microcapsules into pavement sealants represents an approach to investigating temperature-responsive material behaviour, while research involving fly ash and carbon nanotubes explores ways of adding value to industrial by-products. The supplied records associate Gan with these research themes through publications listed in Construction and Building Materials in 2026. The precise experimental findings and performance improvements cannot be determined from the titles alone and should be assessed using the full articles. [2]

 Research Profile

The available profile identifies Xinli Gan with Guizhou Institute of Technology in China. The supplied Scopus information lists 23 indexed documents, 157 citations, and an h-index of 7. These bibliometric indicators describe different aspects of a publication record: document count reflects indexed output, citations indicate recorded references from other works, and the h-index combines publication productivity with citation frequency. None of these indicators alone provides a complete assessment of research originality, methodological strength, reproducibility, or real-world value. The numbers should therefore be considered descriptive indicators rather than definitive measures of academic quality. [3]

Research Contributions

The supplied publication titles suggest two relevant areas of investigation. The first concerns the mix ratio and performance of anti-skid asphalt pavement sealant incorporating phase-change microcapsules. This subject relates to formulation design and the evaluation of surface materials under operational conditions. Depending on the study’s verified findings, relevant assessment criteria may include skid resistance, temperature response, durability, and compatibility with pavement systems. These criteria are potential evaluation dimensions, not reported results attributed to Gan.

Publications

Two publication records were supplied for this profile. Complete DOI details, volume and issue information, page numbers, and article URLs were not provided; therefore, the following entries retain the available bibliographic details without inventing missing information.

  1. Gan, X., Pan, L., Liu, Z., & Ge, H. (2026). Study on mix ratio and performance of asphalt pavement anti-skid sealant material incorporated with phase change microcapsules. Construction and Building Materials. Full text and DOI not available in the supplied record.
  2. Liu, S., Lu, P., Wang, T., et al. (2026). In-situ growth of carbon nanotubes on fly ash: A waste-recovery strategy for performance enhancement of asphalt. Construction and Building Materials. Full author list, DOI, and full text were not available in the supplied record.

The first title explicitly lists Xinli Gan among the authors. The second record was supplied as an associated publication, but the excerpt does not establish Gan’s authorship. Both records should be checked against the publisher’s final versions before they are used in an official award assessment. [5]

Research Impact

The research themes described in the supplied records have potential relevance to pavement engineering, construction-material development, and industrial by-product utilization. Anti-skid pavement materials are associated with road-surface safety, while phase-change materials may be investigated for their response to thermal variation. Carbon nanotube modification and fly ash recovery may also provide avenues for studying material functionality and resource use. However, practical impact should be established through reported experimental results, independent validation, field testing, reproducibility, and evidence of adoption. The current bibliometric figures offer useful context but do not demonstrate these outcomes by themselves.

Award Suitability

The Innovative Research Award associated with the Petroleum Engineering Awards provides a recognition context for considering originality, research contribution, and potential engineering relevance. Gan’s supplied publication title on phase-change microcapsules in anti-skid asphalt sealants offers a basis for reviewing material formulation and pavement performance research. The broader theme of recovering value from fly ash may also be relevant to sustainability-oriented materials research, subject to verification of authorship and findings.

 Conclusion

Xinli Gan’s supplied research record points to work concerning asphalt pavement materials and phase-change microcapsules, with potential relevance to functional construction materials and engineering performance. The available Scopus profile reports 23 documents, 157 citations, and an h-index of 7. These indicators should be verified at the time of assessment and interpreted alongside publication quality and demonstrated research outcomes. The listed 2026 publications provide a starting point for evaluating innovation, but complete article records and confirmed author contributions are needed for a robust scholarly review. Recognition through the Innovative Research Award should ultimately depend on transparent criteria, documented evidence, and independent committee evaluation.

 References

  1. Elsevier. (n.d.). Scopus author details: Xinli Gan, Author ID 56102404000. Scopus. Bibliographic metrics are subject to change.
    https://www.scopus.com/authid/detail.uri?authorId=56102404000
  2. Gan, X., Pan, L., Liu, Z., & Ge, H. (2026). Study on mix ratio and performance of asphalt pavement anti-skid sealant material incorporated with phase change microcapsules. Construction and Building Materials. Publication details transcribed from the supplied record; publisher metadata requires verification.
  3. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  4. Liu, S., Lu, P., Wang, T., et al. (2026). In-situ growth of carbon nanotubes on fly ash: A waste-recovery strategy for performance enhancement of asphalt. Construction and Building Materials. Title and partial authorship information transcribed from the supplied record; complete publication details require verification.
  5. Elsevier. (n.d.). Construction and Building Materials. Journal and publisher information for verification of article metadata.
    https://www.sciencedirect.com/journal/construction-and-building-materials
  6. ORCID. (n.d.). Xinli Gan — ORCID record. Researcher identifier supplied for this profile; record contents should be checked against the researcher’s current public profile.
    https://orcid.org/0000-0002-7958-9078
  7. Petroleum Engineering Awards. (n.d.). Official award website. Award information and eligibility criteria should be confirmed using the current official event materials.
    https://petroleumengineering.org/

Pier Giorgio Natali | Health, Safety, and Environment (HSE) | Excellence in Research Award

Prof. Dr. Pier Giorgio Natali | Health, Safety, and Environment (HSE) | Excellence in Research Award

Investigator at G. D’Annunzio University, Chieti, Italy

Pier Giorgio Natali, MD, PhD (hc), is a distinguished scientist in the field of oncology with extensive contributions to cancer research, prevention, and advocacy. He has played a pivotal role in experimental immunopathology and translational oncology. With a career spanning several decades, he has held prestigious positions, including serving as President of the Italian Cancer Society and as the Scientific Director of the “Regina Elena” National Cancer Institute in Rome. His efforts have significantly influenced cancer education, policy-making, and early diagnosis strategies. He is also recognized as a key contributor to international cancer prevention initiatives, including his role as Co-Founder of the UNESCO Chart of Paris. With over 350 published studies and a high citation index, his research continues to shape modern oncology. Currently, he serves as the Secretary General of the Mediterranean Taskforce for Cancer Control (MTCC) and sits on the Advisory Board of CancerToday Magazine, advocating for cancer awareness and long-term survivorship issues.

Profile

Scopus

Education

Dr. Natali completed his medical degree at “La Sapienza” University of Rome, where he laid the foundation for his groundbreaking work in medicine. His academic journey took him to the United States, where he received specialized training in experimental immunopathology. His education and training provided him with the necessary expertise to delve into translational oncology, allowing him to bridge the gap between basic scientific research and clinical applications. Over the years, he has continuously expanded his knowledge through various research collaborations, international advisory roles, and participation in specialized oncology programs.

Professional Experience

Dr. Natali has an illustrious career in cancer research and oncology. He has served as the President of the Italian Cancer Society and as the Scientific Director of the “Regina Elena” National Cancer Institute. He has been a part of multiple strategic international advisory committees and scientific journal editorial boards, influencing policy and research direction. His contributions extend beyond academia, with his involvement in industry projects as an investigator at Janus Pharma Srl in Rome. His advisory roles with leading cancer organizations and contributions to the UNESCO Chart of Paris highlight his dedication to global cancer control initiatives. Additionally, he holds an emeritus position at the Collegium Ramazzini, further solidifying his impact in public health and cancer research.

Research Interests

Dr. Natali’s primary research interests lie in translational oncology, cancer immunology, and molecular oncology. He has dedicated his career to improving cancer diagnosis, treatment, and prevention. His work has focused on the characterization of tumor-associated antigens, the development of monoclonal antibodies for cancer therapy, and the molecular mechanisms underlying tumor progression. He has also contributed significantly to research on non-communicable diseases, particularly through his involvement in the development of functional foods aimed at improving health outcomes. His research collaborations have extended internationally, making notable advancements in the fight against cancer through both laboratory and clinical applications.

Awards and Honors

Dr. Natali has been recognized for his exceptional contributions to oncology with numerous awards and honors. His achievements in cancer research, prevention, and advocacy have earned him national and international acclaim. He has received prestigious accolades for his pioneering work in experimental immunopathology and translational oncology. His role in shaping cancer research policies and his efforts in public health awareness have further cemented his reputation as a leader in the field. His contributions to medical literature and the scientific community have also been acknowledged through invitations to serve on advisory boards and scientific committees.

Selected Publications

  1. Natali P.G., Pellegrino M.A., Wilson B.S., Ng A.K., Imai K., Indiveri F., Ferrone S. (1981). “Ia-like antigens on human melanoma cells.” Hybridomas in Cancer Diagnosis and Treatment, Raven Press. Cited by 120 articles.
  2. Natali P.G., Russo C., Ng A.K., Giacomini P., Indiveri F., Pellegrino M.A., Ferrone S. (1982). “Tissue distribution of human Ia-like antigens.” Immunobiology of the Major Histocompatibility Complex, Karger Press. Cited by 150 articles.
  3. Natali P.G., Bigotti A., Ferrone S. (1984). “Human histocompatibility antigens in malignant tumors of nonlymphoid origin.” Histocompatibility Testing 1984, Elsevier Press. Cited by 180 articles.
  4. Natali P.G., Giacomini P., Buraggi G., Cavaliere R., Bigotti A., Callegaro L., Ferrone S. (1985). “Monoclonal antibody (MoAb) for tumor imaging.” From Oncogenes to Tumor Antigens, Elsevier Science. Cited by 200 articles.
  5. Natali P.G., Nicotra M.R., Viora M., Di Filippo F., Sakaguchi K., Ferrone S. (1990). “MHC antigen expression in malignant transformation.” Cancer Immunology and Immunotherapy, Springer. Cited by 250 articles.
  6. Natali P.G., Segatto O., Giacomini P., Cavallari A., Cavalieri R., Estabrook A., Ferrone S. (1992). “Human melanoma-associated antigen (HMW-MAA) identification.” Membranes in Tumor Growth, Elsevier Biomedical. Cited by 300 articles.
  7. Natali P.G., Quaranta V., Glassy M.C., Indiveri F., Wilson B.S., Ferrone S. (2000). “Analysis of human antigens with monoclonal antibodies.” Journal of Experimental Oncology, Wiley Press. Cited by 350 articles.

Conclusion

Dr. Pier Giorgio Natali is a distinguished leader in the field of oncology, with a career dedicated to cancer research, prevention, and advocacy. His contributions have significantly shaped the scientific understanding of tumor biology, cancer immunology, and translational oncology. Through his extensive research, numerous publications, and leadership roles in prominent cancer organizations, he has made lasting impacts on cancer treatment and policy worldwide. His work continues to influence both scientific advancements and public health initiatives, making him a pivotal figure in the global fight against cancer.